SLITRK4 and hepatocellular carcinoma: According to existing publications, miR-139-5p inhibits HCC progression by targeting several genes, such as ZEB1 and ZEB2 31, EZH2 52, SPOCK1 32, ETS1 33, XIST 53 and SLITRK4 34.